SCHEMBL603943

SCHEMBL603943

CC(C)(C)NCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6050323 0.79
SCHEMBL126692 0.77
SCHEMBL1717828 0.76 HMGCR (0.41)
SCHEMBL41886 0.76
SCHEMBL1719787 0.74
Hydrochloric Acid SCHEMBL10866624 0.74
Hydrochloric Acid SCHEMBL11284793 0.74 DPP4 (0.38)
SCHEMBL10245077 0.74
SCHEMBL8431006 0.74
Hydrochloric Acid SCHEMBL1092821 0.74 HMGCR (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108546269-A The method that clavulanic acid tert-butylamine salt is recycled from crystalline mother solution 国药集团威奇达药业有限公司 2018-09-18 CN claimed
US-20030027889-A1 Antimicrobial paste glues CREAVIS GESELLSCHAFT F. TECHN. U. INNOVATION MBH (DE) 2003-02-06 US claimed
US-20030019813-A1 Antimicrobial polymer foams with amino alcohols DE GUSSA AG (DE) 2003-01-30 US claimed
EP-1277820-A2 Antimicrobial adhesives Creavis Gesellschaft für Technologie und Innovation mbH (DE) 2003-01-22 EP claimed
EP-1269843-A1 Antimicrobial polymer foams with aminoalcohols Creavis Gesellschaft für Technologie und Innovation mbH (DE) 2003-01-02 EP claimed
WO-2002082903-A1 ANTIMICROBIAL REACTIVE FORMULATIONS COMPRISING AMINOALCOHOLS CREAVIS GESELLSCHAFT FÜR TECHNOLOGIE UND INNOVATION MBH (DE) 2002-10-24 WO claimed
WO-2002064642-A1 METHOD FOR PRODUCING MICROBICIDAL SURFACES BY IMMOBILIZING AMINOALCOHOLS CREAVIS GESELLSCHAFT FÜR TECHNOLOGIE UND INNOVATION MBH (DE) 2002-08-22 WO claimed
US-20260007660-A1 TREATMENT AND PREVENTION OF SLEEP DISORDERS PURDUE PHARMA L.P. (US) 2026-01-08 US disclosed
US-12370191-B2 Treatment and prevention of sleep disorders PURDUE PHARMA L.P. (US) 2025-07-29 US disclosed
US-20250134886-A1 SLEEP DISORDER TREATMENT AND PREVENTION PURDUE PHARMA L.P. (US) 2025-05-01 US disclosed
WO-2025085818-A1 SUNOBINOP FOR USE IN METHOD OF TREATING ALCOHOL USE DISORDER PURDUE PHARMA L.P. (US) 2025-04-24 WO disclosed
US-12171762-B2 Sleep disorder treatment and prevention PURDUE PHARMA L.P. (US) 2024-12-24 US disclosed
CN-118591539-A Substituted thiazolidinedione derivative compounds and pharmaceutical composition for preventing or treating cancer comprising the same (株)美迪菲 2024-09-03 CN disclosed
US-4973679-A Process for oligonucleo tide synthesis using phosphormidite intermediates UNIVERSITY PATENTS, INC. (US) 1990-11-27 US disclosed
EP-0382213-A2 Biphenyl derivative, nerve cell degeneration repairing or protecting agent and process for preparing a phenyl derivative contained in the agent OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1990-08-16 EP disclosed
WO-1989009221-A1 OLIGONUCLEOTIDE N-ALKYLPHOSPHORAMIDATES UNIVERSITY OF VIRGINIA ALUMNI PATENTS FOUNDATION (US) 1989-10-05 WO disclosed
US-4668777-A POLYNUCLEOTIDE INTERMEDIATES UNIVERSITY PATENTS, INC. (US) 1987-05-26 US disclosed
EP-0061746-B1 PHOSPHORAMIDITE COMPOUNDS AND THEIR USE IN PRODUCING OLIGONUCLEOTIDES UNIVERSITY PATENTS, INC. (US) 1985-03-20 EP disclosed
US-4500707-A Nucleosides useful in the preparation of polynucleotides UNIVERSITY PATENTS, INC. (US) 1985-02-19 US disclosed
EP-0061746-A1 Phosphoramidite compounds and their use in producing oligonucleotides UNIVERSITY PATENTS, INC. (US) 1982-10-06 EP disclosed